Delivery and formulation of engineered nucleic acids
US-2024252645-A1 · Aug 1, 2024 · US
US11781146B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11781146-B2 |
| Application number | US-201917054935-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 13, 2019 |
| Priority date | May 24, 2018 |
| Publication date | Oct 10, 2023 |
| Grant date | Oct 10, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides mammalian cell expression vectors that impart to mammalian host cells an ability to produce high levels of foreign gene-derived proteins. A ubiquitously acting chromatin opening element (UCOE) is introduced into an expression vector that has a plasmid DNA integrated into a transcriptional hot spot on the chromosome of a dihydrofolate reductase gene-deficient host cell so that it allows for selection of strains that grow in hypoxanthine-thymidine (hereinafter denoted as HT)-free medium, whereby transformants will produce a protein of interest in increased amounts.
Opening claim text (preview).
The invention claimed is: 1. An expression vector comprising the following (a), (b) and (c): (a) a translation-impaired dihydrofolate reductase gene cassette (translation-impaired DHFR gene cassette) comprising a region with altered codons, wherein the altered codons comprise GCA for alanine, CGA for arginine, AAU for asparagine, GAU for aspartic acid, UGU for cysteine, CAA for glutamine, GAA for glutamic acid, GGU for glycine, CAU for histidine, UUA for leucine, AAA for lysine, CCA for proline, UUU for phenylalanine, UCA for serine, ACU for threonine, UAU for tyrosine, and/or GUA for valine, and wherein the region with altered codons accounts for 30% or more of the full length of the DHFR gene from the 5′ end of the DHFR gene; (b) a gene cassette comprising a cloning site for integration of a foreign gene between a transcriptionally active promoter and a stable polyadenylation signal; and (c) a ubiquitously acting chromatin opening element (UCOE), wherein the UCOE comprises the nucleotide sequence as shown in SEQ ID NO: 1. 2. The expression vector of claim 1 , wherein the translation-impaired DHFR gene cassette of (a) uses a promoter derived from a gene of a non-mammalian cell or a promoter whose enhancer portion has been removed. 3. A method for producing a transformant that produces a foreign gene-derived protein, which comprises integrating a foreign gene into the expression vector of claim 1 , and transforming a dihydrofolate reductase gene-deficient host cell with the expression vector. 4. A method for producing a foreign gene-derived protein, which comprises the following (a) to (d): (a) integrating a foreign gene into the expression vector of claim 1 ; (b) transforming a dihydrofolate reductase gene-deficient host cell with the expression vector; (c) culturing the resultant transformant in a hypoxanthine-thymidine-free medium; and (d) collecting the foreign gene-derived protein from the cultured transformant. 5. The method of claim 4 , wherein a chemically defined medium (CD medium) or a CD medium supplemented with non-animal-based additives is used for culturing in (c). 6. A method of screening for a transformant that produces a foreign gene-derived protein, which comprises the following (a), (b) and (c): (a) integrating a foreign gene into the expression vector of claim 1 ; (b) transforming a dihydrofolate reductase gene-deficient host cell with the expression vector; and (c) culturing the resultant transformant in a hypoxanthine-thymidine-free medium. 7. A foreign gene expression vector which has a foreign gene integrated into the expression vector of claim 1 . 8. A host cell which has been transformed with the foreign gene expression vector of claim 7 . 9. A method for producing a transformant that produces a foreign gene-derived protein, which comprises integrating a foreign gene into the expression vector of claim 2 , and transforming a dihydrofolate reductase gene-deficient host cell with the expression vector. 10. A method for producing a foreign gene-derived protein, which comprises the following (a) to (d): (a) integrating a foreign gene into the expression vector of claim 2 ; (b) transforming a dihydrofolate reductase gene-deficient host cell with the expression vector; (c) culturing the resultant transformant in a hypoxanthine-thymidine-free medium; and (d) collecting the foreign gene-derived protein from the cultured transformant. 11. A method of screening for a transformant that produces a foreign gene-derived protein, which comprises the following (a), (b) and (c): (a) integrating a foreign gene into the expression vector of claim 2 ; (b) transforming a dihydrofolate reductase gene-deficient host cell with the expression vector; and (c) culturing the resultant transformant in a hypoxanthine-thymidine-free medium. 12. A foreign gene expression vector which has a foreign gene integrated into the expression vector of claim 2 . 13. The expression vector according to claim 1 , wherein the expression vector comprises more than one UCOE. 14. The expression vector according to claim 13 , wherein the UCOEs are introduced in such positions that the gene cassette of (b) is sandwiched therebetween. 15. The expression vector according to claim 2 , wherein the expression vector comprises more than one UCOE. 16. The expression vector according to claim 15 , wherein the UCOEs are introduced in such positions that the gene cassette of (b) is sandwiched therebetween. 17. A method for producing a transformant that produces a foreign gene-derived protein, which comprises integrating a foreign gene into the expression vector of claim 13 , and transforming a dihydrofolate reductase gene-deficient host cell with the expression vector. 18. A method for producing a foreign gene-derived protein, which comprises the following (a) to (d): (a) integrating a foreign gene into the expression vector of claim 13 ; (b) transforming a dihydrofolate reductase gene-deficient host cell with the expression vector; (c) culturing the resultant transformant in a hypoxanthine-thymidine-free medium; and (d) collecting the foreign gene-derived protein from the cultured transformant. 19. A method of screening for a transformant that produces a foreign gene-derived protein, which comprises the following (a), (b) and (c): (a) integrating a foreign gene into the expression vector of claim 13 ; (b) transforming a dihydrofolate reductase gene-deficient host cell with the expression vector; and (c) culturing the resultant transformant in a hypoxanthine-thymidine-free medium. 20. A foreign gene expression vector which has a foreign gene integrated into the expression vector of claim 13 .
General methods for enhancing the expression · CPC title
General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease · CPC title
for animal cells · CPC title
Dihydrofolate reductase (1.5.1.3) · CPC title
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.